Daily THC Causes Inflammation in Adolescent Brain Amygdala — CBD Prevents It
Daily THC exposure caused inflammatory gliosis specifically in the amygdala of adolescent — but not adult — primates and rats, and co-administration of CBD prevented this inflammation.
Quick Facts
What This Study Found
THC induced GFAP and complement factor-B upregulation (proinflammatory gliosis) exclusively in the adolescent amygdala, not in other brain regions or adults. THC also reduced synaptic plasticity markers (stathmin-1, NrCAM). CBD co-treatment prevented astrogliosis but did not restore synaptic plasticity markers. The vulnerability was traced to astrocyte-localized CB1R expression specifically in the amygdala.
Key Numbers
Adolescent-specific GFAP and complement factor-B upregulation in amygdala. CB1R expression: astrocyte-localized in amygdala, neuronal in cortex and striatum. CBD prevented gliosis but not synaptic plasticity loss. Astrogliosis correlated with fragmented sleep; reduced plasticity correlated with anxiety.
How They Did This
Multi-species study: proteomic analysis of amygdala from adolescent squirrel monkeys chronically treated with THC, validated in adolescent (P35) and adult (P70) rats. Behavioral testing, primary astrocyte cultures for mechanistic studies. CB1 knockout cells used as controls.
Why This Research Matters
This study provides a molecular mechanism for why adolescent cannabis use increases risk of anxiety and neuropsychiatric disorders: THC specifically inflames the adolescent amygdala (the brain region governing fear and emotion). The CBD protective effect is clinically significant.
The Bigger Picture
The finding that CBD can prevent THC-induced brain inflammation in adolescents has important implications for harm reduction. As cannabis products increasingly contain high THC with minimal CBD, adolescent users may be at greater risk than those using balanced products.
What This Study Doesn't Tell Us
Animal models (primate and rat) may not fully recapitulate human adolescent brain development. CBD prevented inflammation but not all THC-induced changes. Chronic dosing regimen may not match typical human use patterns.
Questions This Raises
- ?Would balanced THC:CBD cannabis products be safer for adolescent brain development?
- ?Is the amygdala inflammation reversible after THC cessation?
Trust & Context
- Key Stat:
- Evidence Grade:
- Strong preclinical design with two species, CB1 knockout controls, and behavioral correlation, but animal-to-human translation uncertain.
- Study Age:
- 2025 publication.
- Original Title:
- Astrogliosis Occurs Selectively in Amygdala of Adolescent Primate and Rodent Following Daily Δ9-Tetrahydrocannabinol, Prevented by Cannabidiol Co-Treatment.
- Published In:
- Biological psychiatry global open science, 5(4), 100496 (2025)
- Authors:
- Sun, Yalin, Sivasubramanian, Meenalochani(2), Milenkovic, Marija(2), Gumbert, Andrew, Bergman, Jack, Ge, Preston, Heiman, Myriam, Di Raddo, Marie-Eve, Withey, Sarah L, Madras, Bertha K, George, Susan R
- Database ID:
- RTHC-07751
Evidence Hierarchy
Frequently Asked Questions
Does THC damage the teenage brain?
This study found daily THC caused inflammatory changes specifically in the amygdala (emotion center) of adolescent primates and rats, but not in adults. This inflammation was linked to disrupted sleep and anxiety behavior, providing a mechanism for why teen cannabis use increases neuropsychiatric risk.
Can CBD protect against THC brain damage?
In this study, CBD co-administration prevented the inflammatory gliosis caused by THC in the adolescent amygdala. However, CBD did not restore synaptic plasticity markers that THC reduced, suggesting partial but not complete protection.
Read More on RethinkTHC
- CBD-oil-quality-guide
- anxiety-medication-after-quitting-weed
- cannabis-chemotherapy-nausea
- cannabis-chronic-pain-research
- cannabis-epilepsy-CBD-Epidiolex
- cbd-anxiety-research-evidence
- cbd-for-weed-withdrawal
- cbd-vs-thc-difference
- medical-benefits-of-cannabis
- quitting-weed-before-surgery
- quitting-weed-medication-interactions
- quitting-weed-pregnancy
- quitting-weed-pregnant
- seniors-older-adults-cannabis-risks-medications
- weed-breastfeeding-THC-breast-milk
Cite This Study
https://rethinkthc.com/research/RTHC-07751APA
Sun, Yalin; Sivasubramanian, Meenalochani; Milenkovic, Marija; Gumbert, Andrew; Bergman, Jack; Ge, Preston; Heiman, Myriam; Di Raddo, Marie-Eve; Withey, Sarah L; Madras, Bertha K; George, Susan R. (2025). Astrogliosis Occurs Selectively in Amygdala of Adolescent Primate and Rodent Following Daily Δ9-Tetrahydrocannabinol, Prevented by Cannabidiol Co-Treatment.. Biological psychiatry global open science, 5(4), 100496. https://doi.org/10.1016/j.bpsgos.2025.100496
MLA
Sun, Yalin, et al. "Astrogliosis Occurs Selectively in Amygdala of Adolescent Primate and Rodent Following Daily Δ9-Tetrahydrocannabinol, Prevented by Cannabidiol Co-Treatment.." Biological psychiatry global open science, 2025. https://doi.org/10.1016/j.bpsgos.2025.100496
RethinkTHC
RethinkTHC Research Database. "Astrogliosis Occurs Selectively in Amygdala of Adolescent Pr..." RTHC-07751. Retrieved from https://rethinkthc.com/research/sun-2025-astrogliosis-occurs-selectively-in
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkTHC research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.